Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Monoclonal Gammopathy of Undetermined Significance 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Psychological Well-Being 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Esophageal Neoplasms 1Castration Sensitive Prostate Cancer 1

Interventions

ruxolitinib 4Specimen Handling 3Biopsy 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2talazoparib 1poly ICLC 1piperine 1iadademstat 1fludarabine phosphate 1fludarabine 1fedratinib 1demethoxycurcumin 1decitabine and cedazuridine drug combination 1bomedemstat 1X-Rays 1Whole-Body Irradiation 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Positron-Emission Tomography 1N(4)-oleylcytosine arabinoside 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Injections 1Hematopoietic Stem Cell Transplantation 1Decitabine 1Cyclophosphamide 1Curcumin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thrombocythemia, Essential × Curcumin × Clear all
NCT06063486 2026-03-27

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

University of Southern California

Phase 2 Recruiting
30 enrolled
Myeloid

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡